- Catégorie parente: AST Annales des Sciences et Technologie
Mohamed Dehamchiaa,b* and Zine Régaïniaa
aLaboratory of Applied Organic Chemistry, ChemistryofHeterocycles Group,Department of Chemistry, Badji Mokhtar University of Annaba, PO Box 12, 23000, Algeria.
bLaboratory of VTRS, FacultyofSciences and Technology, El Oued University, PO Box 789, 39000, Algeria
RESUMÉ :Les sulfamides cycliques sont N-acylés et N-alkylés de manière efficace avec différents groupes alkyle, benzyle et halogénures d'acyles. Les réactions ont été réalisées dans des conditions d'irradiation par micro-ondes avec ou sans solvant. Une comparaison avec les méthodes classiques démontre les avantages de l'application des micro-ondes comme une méthode non-classique d’activation en synthèse organique et les transformations chimiques. Les structures des composés synthétisés ont été identifiées grâce à leurs données analytiques et spectrales.
MOTS-CLÉS : Micro-ondes ; Sulfamides cycliquies ; halogénure d’alkyle ; halogénures d’acyles ; N-alkylation ; N-acylation.
ABSTRACT: Cyclic sulfamides were efficiently N-acylated and N-alkylated with different alkyl, benzyl and acylhalides. The reactions were carried out under microwave irradiation conditions with and without solvent. A comparison with conventional methods demonstrates the advantages of applying microwave irradiation as a non-conventional method for activation in organic syntheses and chemical transformations. The structures of the synthesized compounds were inferred from their analytical and spectral data.
KEYWORD: Microwave; Cyclic sulfamides; alkyl halide; acyl halide; N-alkylation; N-acylation.
Sulfamide-containing-heterocycles (cyclic sulfamides) are of great interest because of their manifold applications as intermediates for biologically active molecules. Many products that contain a sulfamide moiety exhibit biological activity such as anti-HIV protease  and some serving as metalloprotease inhibitors  and nonhydrolyzable peptidomimetics .
In recent years, 1,2,5-thiadiazolidine 1,1-dioxide compounds 1, 2 and 3 have been among the most extensively investigated classes of organic compounds, with a wide spectrum of biological activity [4-6]. These compounds are known to inhibit several families of enzymes, including serine proteases [7-8], γ-secretases  and constrained peptides [10-11].Additionally, fused heterocyclic derivatives with the thiadiazolidine moiety are also used as drug and pesticide intermediates.
Considering the biological importance of N-substituted cyclic sulfamides and our interest in environmentally chemical transformations ,we report in this paper the results of our studies on N-acylation and N-alkylation of non-N-substituted cyclic sulfamides using microwave irradiation with and without solvent. The application of this methodology has become sustainable and powerful tool in chemical synthesis, since by using this technique of activation it is possible to synthesize organic compounds with high purity and in better yields, compared with other conventional methods [13-16]. The synthetic pathways are depicted in Scheme 1. Starting materials 1a -1q were prepared according to published procedures [17-20].
In continuation of our research on the development of simple methods for the synthesis of useful compounds, we report a novel method for the N-alkylation of cyclic sulfamides with alkyl halides with a route using microwave irradiation .The results in Table 1 indicate the isolation of products 2a-2q using three methods, however in different yields.
Using a microwave oven as the energy source, we optimized the reaction conditions of alkylation by testing different parameters such as different bases and solvents. The best results were obtained employing K2CO3or Cs2CO3in N, N-dimethylformamide (DMF) or acetonitrile (CH3CN) . As an example, with K2CO3/DMF, the alkylated product 2g was obtained in good yield (98 %) in four minutes, whereas conventional process requires three hours. Moreover, the effects of solvents such as CH3CN, DMF and basic aqueous medium (H2O/base) were also studied (compounds 2a, 2b and 2c). The yields of 2a, 2b and 2c were 90%, 88% and 90%, respectively. The results revealed that the solvents do not show any influence on the alkylation yield.
As is evident from Table 1, under MW conditions the reaction times decrease from several hours to five minutes, and the amount of solvent was reduced using microwave irradiation.
The nucleophilic substitution at the nitrogen atom of 1,2,5-thiadiazolidine 1,1-dioxides has also been achieved using microwave irradiation under solvent-free conditions . The reactions were carried out by thoroughly mixing cyclic sulfamide with 2 equiv of an alkyl halide, catalytic amount (0.01 equiv) of tetra-butylammonium bromide and anhydrous potassium carbonate followed by irradiation in a microwave at 300 W for the given time (see Table 1) . Extraction three times with methylene chloride and chromatographic purification on a silica gel column gave the N-alkylthiadiazolidine 1,1-dioxides dérivatives 2a -2o in yields generally greater than 85% (Table 1). The Solvent-Free MWI protocols provides an opportunity to work with open vessels, thus avoiding the various risks and problems associated with the use of organic solvents .
2.2. N-Acylation of cyclic sulfamides
Conventional N-acylation reaction was carried out by treatment of non-N-substituted cyclic sulfamides (N5H-1,2,5-thiadiazolidine and N6H-1,2,6-thiadiazinane) with a series of acylating agents (acylchlorides, anhydrides or carboxylic acids) under basic conditions (Triethylamine, pyridine, dimethylaminopyridyne or NaH) (see Table 2). Another approach to the N-acylation of cyclic sulfamides utilizes concentrated H2SO4 in carboxylic acid anhydride as solvent (3c) or dry organic solvent such as CH3CN or DMF (compounds 3f and 3k) , [26-29].
To choose the suitable solvent for the acylation, the model reaction was tested in different solvents under thermal conditions. The results are shown in Table 2.
However, most of the published protocols suffer from more disadvantages such as long reaction time, low yield of product and use of dangerous reagents and solvent.
Since the aim of our current research is concernedwith achieving reasonable yields in the synthesis of substituted heterocyclic compounds which might have potential biological activities, compounds 3a-3m (Table 2) were also obtained under microwave conditionsfollowing two methodologies .
First, we examined the N-acylation of non-N-substituted cyclic sulfamides with acylating agent using K2CO3 or H2SO4 in dry organic solvent under microwave irradiation (Table 2). The use of microwave irradiation was effective in that the reaction was completed within 2-10 minutes. In contrast, the reaction was completed (as monitored by thin-layer chromatography) in 4-5 hours in the case of classical heating (Table 2).
In order to find the best conditions for the formation of N-acylated cyclic sulfamides 3a-3m,the reactions were performed with microwave under solvent-free conditions. As indicated in Table 2, compounds 3a-3m were obtained in high yields within short reaction times. The N-acylated products were obtained by simple cold aqueous work-up followed by extraction with methylene chloride and were finally chromatographed on silica gel column to afford pure N-acylated-cyclic sulfamides.
The enhanced reactivity under microwave irradiation was evident by comparison with the reactions under classical conditions (Table 2). N-Acylation under conventional heating conditions required longer reaction times and N-acylated cyclic sulfamides were obtained in lower yields, while the acylation under microwave irradiation gave higher purity and yields of the desired products in 3 to 10 minutes. This technique using microwave irradiation can be said to be a simple, improved and eco-friendly procedure to obtain N-acylated and N-alkylated cyclic sulfamide derivatives. The formation of products 2a-2q and 3a-3m was confirmed by interpretation of their FT-IR, 1H-NMR and mass spectra.
We have presented a novel, highly rapid, efficient and solvent‐free protocol for the N-acylation and N-alkylation of non-N-substituted cyclic sulfamide derivatives using a microwave oven as the irradiation source in organic solvent and aqueous medium and under solvent-free conditions. This study leads to a better understanding of N-alkylation and N-acylation of cyclic sulfamide derivatives. Further developments of this work and the evaluation of product biological activities are currently in progress.
All commercial chemicals and solvents used were analytical grade and were used as received. 1H NMR (300 MHz) and 13C NMR (75 MHz) spectra were recorded on a Bruker Avance spectrometer. Chemical shifts were reported in ppm with respect to internal TMS. Coupling constants (J) are quoted in Hz. Infrared spectra were recorded on a Shimadzu FT-IR 8400S spectrophotometer. The mass spectrometry data were obtained using a Hewlett Packard 5989 A instrument at 70 eV for the EI spectra and using methane as the reagent gas for CI spectra. Microwave irradiation was performed in a modified domestic microwave oven (Galanz WP-750B).
4.2. Conventional Heating Procedure for N-Alkylation of Cyclic Sulfamides.
To a stirring solution of non-N5-substituted1,2,5-thiadiazolidine 1,1-dioxides (cyclic sulfamides) 1a-1m (1 equiv, 1 mmol) in dry organic solvent (CH3CN, DMF,…) or H2O (20 mL) in a 100mL round bottom flask was added K2CO3 (2.5 equiv, 2.5 mmol) or Cs2CO3 (2.5 equiv, 2.5 mmol). Alkylating agent, alkyl halide (1 equiv, 1 mmol) was added slowly and the resulting mixture was stirred at reflux for the appropriate time then cooled to room temperature. The reaction mixture was filtered and the filtrate was evaporated under reduced pressure. The residue was dissolved in CH2Cl2, washed with 2 portions of HCl 1M (2x10 mL), water (2x10 mL), dried over Na2SO4 and the solvent was removed under reduced pressure to give the crude oil. Flash chromatography on silica gel CH2Cl2 to furnish the pure N-alkyl-cyclic sulfamide in 65–85% yields the following.
4.3. Microwave-Assisted Procedurefor N-Alkylation of Cyclic Sulfamides.
Compounds 2a-2o were prepared according to previously published protocols . To a stirred solution of non-N5-substituted-1,2,5-thiadiazolidine 1,1-dioxides (cyclic sulfamide) (1 eq, 1 mmol) and an appropriate alkyl halide (1.5 eq, 1.5 mmol) in appropriate solvent (2 ml), K2CO3 (2 mmol, 0.28 g) was added and the mixture was stirred at room temperature for 5 min. Then, the resulting mixture was placed in the microwave and irradiated at 300 W at 100 °C for an appropriate time (as reported in Table II (2 to 10 min). After completion (monitored by TLC), the reaction mixture was cooled, diluted with water (100 mL), neutralised with NaHCO3 and extracted with CH2Cl2(3 x 10 mL); the solvent was evaporated under reduced pressure, and the residue was purified by column chromatography using CH2Cl2 give the N5-alkylated product.
4.4. Microwave-Assisted Solvent-Free Procedurefor N-Alkylation of Cyclic Sulfamides.
Compounds 2a-2owere prepared according to previously published protocol . A mixture of non-N5-substituted-1,2,5-thiadiazolidine 1,1-dioxides (1 equiv, 1 mmol), the appropriate alkyl halide (2 equiv, 2 mmol), base (4 equiv, 4 mmol) and catalytic amount of tetra-butylammonium bromide (TBAB) (0.01 equiv, 0.01 mmol) were mixed in an open conical flask and stirred for a few seconds. The mixture was placed inside the microwave oven, and irradiated at 300 W for the given time (Table 1). After completion of the reaction (monitored by TLC), the product is extracted with methylene chloride. The solvent was removed under reduced pressure and the residue was purified by column chromatography using CH2Cl2 to afford the corresponding N5-alkylated-1,2,5-thiadiazolidine 1,1-dioxides product in yields typically greater than 80%.
4.5. Conventional Procedure for N-Acylation of Cyclic Sulfamides with Acyl Chlorides (for products 3a, 3b, 3e, 3g, 3i, 3j, 3l, 3l, 3m). 
A solution of acyl chloride (1 equiv, 1 mmol) in dry organic solvent (10 mL) was added dropwise to a mixture of non-N5-substituted-1,2,5-thiadiazolidine 1,1-dioxides 1a-1h (1 equiv, 1 mmol) and triethylamine (1.2 equiv) in the same solvent 20 mL in round bottomed flasek and the reaction mixture was left to stir under reflux for 2 to 5 h (monitored by TLC). Upon completion of the reaction, the reaction mixture was cooled to room temperature and followed by solvent removal under reduced pressure. The residue was taken up in CH2Cl2, washed with NaHCO3 (5%, 2x10 mL), brine (2x10 mL), dried over anhydrous Na2SO4 and the solvent was evaporated to give a crude product. Flash chromatography on silica gel using ethyl acetate n-hexane (1:3)as the eluent afforded the corresponding pure N5-acyl-1,2,5-thiadiazolidine 1,1-dioxides.
4.6. Conventional Procedure for N-Acylation of Cyclic Sulfamides with Anhydrides (for products 3c, 3d, 3f, 3i, 3k).
A mixture of non-N5-substituted-1,2,5-thiadiazolidine 1,1-dioxides 1a-1p (1 equiv, 1.0 mmol), carboxylic acid anhydride (1.5 mmol) and 2 drops of conc H2SO4 or three equivalents of appropriate base was stirred for the appropriate time (Table 2). The progress of the reaction was monitored by TLC. After completion of the reaction, the reaction mixture was cooled to room temperature and the solvent was evaporated under reduced pressure. The mixture was diluted with dichloromethane (15 mL), washed with water (2x10 mL) and brine solution (2x10 mL) and dried over Na2SO4. The solvent was evaporated in vacuo and the crude product was purified by column chromatography (n-hexane/ethyl acetate 3/1) to afford the corresponding N5-acyl-1,2,5-thiadiazolidine 1,1-dioxides.
4.7. Conventional Procedure for N-Acylation of Cyclic Sulfamides with Carboxylic Acids (for products 3e, 3g, 3h) .
To a stirred solution of carboxylic acid (1.5 mmol) in dry solvent (10 mL) was added HATU (2 mmol) followed by 3 mmol of appropriate base and non-N-substituted cyclic sulfamides (1.2 mmol) in the some solvent under a nitrogen atmosphere. The mixture was stirred at room temperature for the given time (see Table 3) and the solvent was evaporated under reduced pressure. The residue was diluted with ethylacetate (30 mL) and washed with 5% aqueous HCl (2x10 mL), 5% NaHCO3 (2x10 mL) and brine (2x10 mL) and dried over Na2SO4. The solvent was removed under reduced pressure to afford crude product. The crude product was purified by column chromatography on silica gel eluted with (n-hexanes/ethyl acetate 3:1) to afford the corresponding N-acylated cyclic sulfamides.
4.8. Microwave-Assisted Procedurefor N-Acylation of Cyclic Sulfamides.
A mixture of non-N5-substituted cyclic sulfamide (1 equiv, 1mmol), carboxylic acid anhydrides with 2 drops of conc H2SO4 or acyl chloride (2 equiv, 3 mmol) with 3 equivalents of appropriate base in dry organic solvent (2 mL) was irradiated in microwave oven (300 W, 110 °C) for a few minutes with stirring. After completion of the reaction, the solution was extracted with ethyl acetate (2x10 mL) and the organic layer was washed with aqueous NaHCO3 (5%, 2x10 mL), brine (2x10 mL), dried over anhydrous Na2SO4 and the solvent was evaporated under reduced pressure to provide the crude product. Flash chromatography on silica gel using ethyl acetate n-hexane (1:3)as the eluent afforded the desired N5-acylCyclic sulfamid 2a-2m.
4.9. Microwave-Assisted Solvent-Free Procedurefor N-Acylation of Cyclic Sulfamides.
A mixture of non-N5-substituted Cyclic sulfamide (1 mmol), acid anhydrie (or acyl chloride) and 2 drops of conc H2SO4 (1,5 mmol) (or 3 equivalents of appropriate base) was placed in Teflon microwave vessels. The system was heated in a microwave oven at 300 W for a few minutes (monitored by TLC). On completion of the reaction, the mixture was extracted with ethyl acetate, washed with aqueous NaHCO3 (5%, 2x10 mL), brine (2x10 mL) dried over anhydrous Na2SO4 and solvent removed under reduced pressure. The crude product was purified by column chromatography over silica gel using ethyl acetate n-hexane (1:3)as the eluent.
[N2-(2’)-(propionic acid methyl ester), N5-propionyl]-1,2,5-thiadiazolidine 1,1-dioxide (3f). Compound 3f was prepared using 1h (1 equiv, 1 mmol, 0.208 g). Compound 3f was obtained as white solid in 74% yield by conventional heating, 93% yield by MWI in CH3CN and 90% yield in the MWI solvent-free reaction. TLC: Rf=0.56 (CH2Cl2); m.p= 90-91°C; IR (KBr) ν cm-1: 1750-1715 (C=O), 1375 and 1160 (SO2) ; 1H-NMR (CDCl3, δ ppm): 4.15 (q, J=7.8 Hz, 1H), 3.80 (t, J=6.2 Hz, 2H), 3.70 (s, 3H), 3.65 (t, J=6.7 Hz, 2H), 2.85 (q, J=7.4 Hz, 2H), 1.50 (d, 3H, J=7.8 Hz), 1.15 (t, 3H, J=7.4 Hz, 3H); LRMS (CI): 265 [M+H]+.
N2-Boc-4-isobutyl-N5-(2-(3-methoxyphenyl)acetyl)-1,2,5-thiadiazolidine 1,1-dioxide (3g). Compound 3g was prepared using 1d (1 equiv, 1 mmol, 0.278 g). Compound 3g was obtained as an oil in 31% yield by conventional heating, 80% yield by MWI in toluene and 72% yield in the MWI solvent-free reaction. Rf = 0.57 (SiO2, CH2Cl2); IR (KBr, ν cm-1):1749-1718 (C=O), 1374 and 1159(SO2); 1H NMR (CDCl3, δ ppm): 0.92 (t, 6H, 2CH3), 1.57 (m, 2H, CH2), 1.58 (s, 9H, tBu), 1.63 (m, 1H, CH), 3.78 (m, 2H, CH2), 3.79 (s, 3H, O-CH3), 4.03 (q, 2H, CH2), 4.54 (m, 1H, CH); 6.80-7.22 (m, 4H, H-Ar); LRMS (CI): 427 [M+H] +.
N2-Boc-N5-(2-(3-fluorophenyl)acetyl)-4-isobutyl-1,2,5-thiadiazolidine 1,1-dioxide (3h).Compound 3h was prepared using 1d (1 equiv, 1 mmol, 0.278 g). Compound 3h was obtained as an oil in 28% yield by conventional heating, 70% yield by MWI in CH2Cl2 and 67% yield in the MWI solvent-free reaction. TLC: Rf = 0.53 (SiO2, CH2Cl2); IR (KBr, ν cm-1): 1752-1720 (C=O),1365 and1150 (SO2);1H NMR (CDCl3, δ ppm): 0.92 (t, 6H, 2CH3), 1.57 (m, 2H, CH2), 1.58 (s, 9H, tBu), 1.63 (m, 1H, CH), 3.78 (m, 2H, CH2), 4.02 (q, 2H, CH2), 4.54 (m, 1H, CH), 6.90-7.30 (m, 4H, H-Ar); LRMS (CI): 415 [M+H] +.
N2-Boc-4-isobutyl-N5-(3-phenylpropanoyl)-1,2,5-thiadiazolidine 1,1-dioxide (3l).Compound 3l was prepared using 1d (1 equiv, 1 mmol, 0.278 g). Compound 3n was obtained as an oil in 36% yield by conventional heating, 70% yield by MWI in toluene and 59% yield in the MWI solvent-free reaction. TLC: Rf = 0.49 (SiO2, CH2Cl2); IR (KBr, ν cm-1): 1747-1717 (C=O),1380 and 1139 (SO2);1H NMR (CDCl3, δ ppm): 0.94 (d, 6H, 2CH3), 1.57 (m, 2H, CH2), 1.58 (s, 9H, tBu), 1.61 (m, 1H, CH), 2.98 (m, 3H, CHaHb), 3.10 (m, 1H, CHaHb), 3.73 (m, 2H, CH2), 4.53 (m, 1H, CH); 7.20 (m, 5H, H-Ar); LRMS (CI): 411 [M+H] +.
 Bäckbro K., Löwgren S., Österlund K., Atepo J., Unge T., Hultén J., Bonham N. M., Schaal W., Karlén A. and Hallberg A.; J. Med. Chem. 40, 898-902 (1997).
 Chen J. J, Zhang Y., Hammond S., Dewdney N., Ho T., Lin X., Browner M. F. and Castelhano A. L.; Bioorg. Med. Chem. Lett. 6, 1601–1606 (1996).
 Gante J.; Angewandte Chemie—International Edition in English 33, 1699–1720 (1994).
 Groutas W. C., Kuang R., Ruan S., Epp J. B., Venkataraman R. and Truong T. M.; Bioorg. Med. Chem. 6, 661-671(1998).
Lai Z., Gan X., Wei L., Alliston K. R., Yu H., Li Y. H. and Groutas W. C.; Arch. Biochem. Biophys. 429, 191-197 (2004).
 Groutas W. C., Kuang R. and Venkataraman R.; Biochem. Biophys. Res. Commun. 198, 341-349 (1994).
 Groutas W. C., Kuang R., Venkataraman R., Epp J. B., Ruan S. and Prakash O.; Biochemistry 36, 4739-4750 (1997).
Yang Q., Li Y., Dou D., Gan X., Mohan S., Groutas C. S., Stevenson L. E., Lai Z., Alliston K. R., Zhong J., Williams T. D.and Groutas W. C.;Archives of biochem. and biophy. 475, 115-120 (2008).
 Sparey T., Beher D., Best J., Biba M., Castro J. L., Clarke E., Hannam J., Harrison T., Lewis H., Madin A., Shearman M., Sohal B., Tsou N., Welch C. and Wrigley.; J. Bioorg. Med. Chem. Lett. 15, 4212–4216 (2005).
 Boudjabi S., Dewynter G., Voyer N., Toupet L. and Montero J. L. ; Eur. J. Org. Chem. 9, 2275- 2283 (1999).
Dougherty J. M., Probs D. A., Robinson R. E., Moore J. D., Klein T. A., Snelgrove K. A. and Hanson P. R.; Tetrahedron 56, 9781-9790 (2000).
 Dehamchia M. and Régaïnia Z.; J. Sulfur. Chem. 34, 242-249 (2013).
 Caddick S.; Tetrahedron 51, 10403-10432 (1995).
 Kappe C. O.; Angew. Chem. Int. Ed 43, 6250-6284 (2004).
 Anastas P. T. and Warner J. C.; Green Chemistry: Theory and Practice; Oxford University Press: Oxford, (1998).
 Green Chem. 13, 794 (2011).
 Nicolaou K. C., Snyder S. A., Deborah A. L., Nalbandian A. Z. and Huang X.; Chem. Eur. J 10, 5581-5606 (2004).
Régaïnia Z., Abdaoui M., Aouf N. E., Dewynter G. and Montero J. L.; Tetrahedron 56, 381-387 (2000).
 Johnson P.D., Jewell S. A. and Romero D. L.; Tetrahedron 44, 5483-5485 (2003).
 Nicolaou K. C., Deborah A. L., Scott A. S., Annie Z. N. and Xianhai H.; Angew. Chem. Int. Ed 41, 3866-3870 (2002).
 Katritzky A. R., Lang H. and Lan X.; Tetrahedron 49, 2829-2838 (1993).
Wang X.-j., Sidhu K., Zhang L., Campbell S., Haddad N., Reeves D. C., Krishnamurthy D. and Senanayake C. H.; Org. Lett. 11, 5490-5493 (2009).
Shmidt M. S., Reverdito A. M., Kremenchuzky L., Perillo I. A. and Blanco M. M.; Molecules 13, 831-840 (2008).
 Green. Chem. 1, 43-55 (1999)
Bogdal D.; Molecules 4, 333-337 (1999).
Berredjem M., Djebbar H., Regainia Z., Aouf N.-E., Dewynter G., Winum J.-Y. and Montero J.-L.; Phosphorus. Sulfur. Silicon 178, 693-705 (2003).
Yang T. and Gao G.; Arkivoc. Volume 2012, 304-316 (2012).
Katritzky A. R., Suzuki K. and Singh S. K.; Arkivoc. 12-35 (2004).
 Bendjeddou A., Djeribi R., Regainia Z. and Aouf N. E.; Molecules 10, 1387–1398 (2005).
 Lidstrom P., Tierney J., Wathey B. and Westman J.; Tetrahedron 57, 9225-9283 (2001).